courtesy of AOL, IncVolkswagen may have a compensation agreement with 100,000 workers. (Reuters) The European Union asks telecom companies about Apple Inc.’s (NASDAQ: AAPL) competitive actions against other smartphone companies. (Reuters) Hon…
U.S. equity markets opened higher this morning and maintained the upside, anticipating that today’s FOMC statement would not provoke any surprises. And the markets were not surprised (more coverage here). In Europe,…
ThinkstockIn the most recent trading days, we have seen more companies turn to new or expanded share buyback plans. If the dividend tax rates rise too much, corporations may ditch the endless…
The three major U.S. stock indexes opened flat to slightly lower this morning after the three-day holiday weekend. PMI readings from Europe came out weaker than expected yesterday (our coverage here), as…
Wikimedia Creative Commons, JohnnyMrNinjaThe stock market is down Tuesday, with the Dow Jones Industrial Average down 0.60%, the Nasdaq down 0.44% and the S&P 500 down 0.56%. Today’s winners both include mergers,…
Medicis Pharmaceutical Corp. (NYSE: MRX) is seeing its shares surging on news that it will be acquired by Valeant Pharmaceuticals International Inc. (NYSE: VRX). What is interesting here is that Valeant is…
Jon C. Ogg Samsung will review 250 suppliers for labor violations. (Reuters) Oracle Corp. (NASDAQ: ORCL) will ask a court to review copyright damages against SAP A.G. (NYSE: SAP). (Reuters) Ericsson (NASDAQ: ERIC) is likely…
Privately held Bausch + Lomb Inc. has made ISTA Pharmaceuticals Inc. (NASDAQ: ISTA) an offer it can’t refuse. The eye care company owned by private equity firm Warburg Pincus will acquire ISTA…
Paul Ausick Stocks opened down this morning following on weakness in Europe following the G20’s refusal to provide additional funding to the IMF. But at the end of the first hour of trading, a…
A month ago drug maker Ista Pharmaceuticals Inc. (NASDAQ: ISTA) rejected a takeover bid of $6.50/share in cash from Canadian drug maker, Valeant Pharmaceuticals International, Inc. (NYSE: VRX) as being “grossly inadequate.”…
Paul Ausick Two weeks ago Valeant Pharmaceuticals International, Inc. (NYSE: VRX) made an unsolicited all-cash offer of $6.50/share for ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), a maker of eye-care drugs. The offer valued ISTA at…
Paul Ausick Valeant Pharmaceuticals International, Inc. (NYSE: VRX) has made an unsolicited all-cash offer of $6.50/share for ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), a maker of eye-care drugs. The offer values ISTA at around $327…
Paul Ausick Some companies just want to keep bringing on new share buybacks whether they work or not. Some are to stop dilution from acquisitions or employee stock options, while others are to reduce…
The pace of stock buyback announcements in the month of August was almost unbelievable. The pace was stronger at the start of the month when earnings were still coming in droves, but…
The upcoming week is not very active on the earnings front but we do have some key events to watch for individual equities and companies. This our cast of “The Unusual Suspects”…
